Tag: PSMA PET

Researchers are questioning if PSMA-PET scans, usually reserved for advanced prostate cancer, might offer added value when used alongside mpMRI earlier in diagnosis. Studies suggest a combined approach could improve detection, but questions remain about cost, accuracy, and future role. keep reading

Recent studies are questioning whether prostatectomies can sometimes proceed without a prior biopsy, thanks to high-precision imaging techniques like mpMRI and PSMA PET scans. While this approach offers some benefits, including fewer procedural risks, it sparks important debates about accuracy, patient safety, and treatment planning. keep reading

On May 18, 2025 it was formally announced that former President Joe Biden had been diagnosed with prostate cancer that has spread to bone. Speaking for all of us at the Sperling Prostate Center, our hearts go out to President Biden and his family. How was he diagnosed? According to news reports... keep reading

We’ve posted numerous blogs on the contributions of Artificial Intelligence (AI) to various aspects of MRI detection and diagnosis of prostate cancer (PCa). We’ve reported AI’s ability to predict metastasis, assign Gleason scores and PI-RADS scores, pinpoint tumor margins for focal therapy, rule out need for biopsy, predict PCa metastasis, and more—showing the accuracy and keep reading

Baseball fans are familiar with the Baltimore Orioles, a team named for the state bird of Maryland. Since 1954, the bird has brought them luck: 7 pennants and 3 World Series. Now there’s a new ORIOLE that’s having a winning season in the fight against metastatic prostate cancer. ORIOLE stands for a study called the keep reading

If you were suddenly kidnapped and blindfolded, then abandoned in a foreign land, you would want the best possible map to get safely to the border where you could figure out a homeward-bound plan. For men who are diagnosed with high-risk prostate cancer (PCa), it’s as if a hostile unknown enemy has abducted them, deprived keep reading